ClinConnect ClinConnect Logo
Search / Trial NCT06830473

KTRSensor Scotland Study: An Observational Study Into Predictors and Diagnosis of Kidney Transplant Rejection

Launched by UNIVERSITY OF EDINBURGH · Feb 11, 2025

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

The KTRSensor Scotland Study is a research project aimed at understanding kidney transplant rejection better. This study will look at real-life experiences of patients who have received kidney transplants and are visiting their doctors for regular check-ups. Researchers want to find out if certain biological markers (substances in the body that can indicate health conditions) can help predict how well a transplant is doing and improve patient outcomes.

To participate in this study, you need to be a patient at a Scottish transplant center who has received a kidney transplant (and possibly a pancreas or islet transplant) and is scheduled for follow-up appointments. Unfortunately, if you have never had a kidney transplant before, are visiting a different clinic for follow-ups, or cannot provide urine samples during the study, you won't be eligible. Participants will help researchers collect important data that may lead to better monitoring and treatment for kidney transplant patients in the future.

Gender

ALL

Eligibility criteria

  • Any patient within a Scottish Transplant centre who has undergone renal transplant (+/- pancreas/islet) and is due to attend routine follow-up appointments at the index centre.
  • Exclusion criteria:
  • no previous kidney transplant
  • patient attending follow-up at a peripheral site
  • unable to provide urine samples across the study duration

About University Of Edinburgh

The University of Edinburgh, a prestigious institution renowned for its commitment to research excellence and innovation, serves as a leading clinical trial sponsor dedicated to advancing healthcare through rigorous scientific inquiry. With a strong emphasis on multidisciplinary collaboration, the university facilitates cutting-edge clinical studies that aim to explore novel therapies and improve patient outcomes. Leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, the University of Edinburgh is at the forefront of translating scientific discoveries into practical applications, thereby contributing significantly to the global medical community.

Locations

Glasgow, , United Kingdom

Edinburgh, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Marc Vendrell, PhD

Study Chair

University of Edinburgh

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported